Moderna (MRNA) P/FCF US GAAP (year values) |
|||||||||
2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
P/FCF | 20.3 | 7.68 | 15.4 | 15.4 | -9.93 | -6.91 | |||
Changes by years, y/y, % | -254% | -62% | +101% | 0% | -164% | +28.5% |
Moderna. P/FCF
Moderna. P/FCF, changes, %
Moderna (MRNA) P/FCF US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
P/FCF | -14.8 | -9.91 | -11.1 | -11.5 | -6.50 | -6.91 | ||
Changes by years, y/y, % | -299% | -166% | -111% | -81% | -56% | |||
Changes by quarters, q/q, % | -33% | +12% | +3% | -43% |